Exciting News for Rwanda's Biotechnology & Healthcare Sector!

04 August 2025 Kigali, Rwanda and San Francisco, USA

It was a great pleasure to welcome Dr. Menghis Bairu, CEO of Bio Usawa Biotechnology Ltd, to discuss their groundbreaking plans to establish a first-of-its-kind biotechnology hub in Rwanda, from discovery and R&D to manufacturing life-saving monoclonal antibodies right here on African soil.

This visionary venture will position Rwanda as a pioneer in biotechnology innovation, addressing critical healthcare challenges such as cancer, diabetes-induced eye disorders, autoimmune and infectious diseases, not just for Rwanda, but for the entire continent.

Dr. Bairu's confidence in Rwanda's business-friendly environment and our government's proactive approach to facilitating strategic investments reflects the progress we've made in positioning Rwanda as a premier destination for innovative enterprises. More importantly, this partnership aligns perfectly with our national vision to establish Rwanda as a biotechnology, pharmaceutical manufacturing, and medical tourism hub serving all of Africa.

We are deeply grateful that Bio Usawa has chosen Rwanda for this transformative investment, a testament to our business-friendly environment, proactive government policies, and commitment to positioning Rwanda as a leading life sciences hub in Africa.

The Government of Rwanda, through RDB and our partners is fully committed to this venture and will provide full support to ensure its success. Bio Usawa's mission aligns perfectly with Rwanda's aspirations for universal health coverage, health security, and medical sovereignty.

Together, we are building a future where Africa can discover, develop, and manufacture its own advanced medical solutions closer to the people that need them, reducing dependency on imports and saving lives.